Patents by Inventor Edward Koo
Edward Koo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210137891Abstract: The presently disclosed subject matter relates to methods of administering an effective amount of dexmedetomidine to a pediatric patient in order to reduce the incidence of neurological damage. More particularly, the presently disclosed subject matter relates to methods of providing sedation or analgesia to a pediatric patient by administering a dexmedetomidine infusion and optionally a loading dose. The dexmedetomidine can be administered before, during, or after surgery.Type: ApplicationFiled: November 11, 2020Publication date: May 13, 2021Applicant: Hospira, Inc.Inventors: Marcelo Garcia da Rocha, Wayne Wisemandle, Dennis James Stalker, Edward Koo
-
Publication number: 20190269657Abstract: The presently disclosed subject matter relates to methods of administering an effective amount of dexmedetomidine to a pediatric patient in order to reduce the incidence of neurological damage. More particularly, the presently disclosed subject matter relates to methods of providing sedation or analgesia to a pediatric patient by administering a dexmedetomidine infusion and optionally a loading dose. The dexmedetomidine can be administered before, during, or after surgery.Type: ApplicationFiled: May 21, 2019Publication date: September 5, 2019Applicant: Hospira, Inc.Inventors: Marcelo Garcia da Rocha, Wayne Wisemandle, Dennis James Stalker, Edward Koo
-
Patent number: 9314449Abstract: The presently disclosed subject matter relates to methods of administering an effective amount of dexmedetomidine to a pediatric patient in order to reduce the incidence of neurological damage. More particularly, the presently disclosed subject matter relates to methods of providing sedation or analgesia to a pediatric patient by administering a dexmedetomidine infusion and optionally a loading dose. The dexmedetomidine can be administered before, during, or after surgery.Type: GrantFiled: December 24, 2012Date of Patent: April 19, 2016Assignee: HOSPIRA, INC.Inventors: Marcelo Garcia da Rocha, Wayne Wisemandle, Dennis Stalker, Edward Koo
-
Publication number: 20160067220Abstract: The presently disclosed subject matter relates to methods of administering an effective amount of dexmedetomidine to a pediatric patient in order to reduce the incidence of neurological damage. More particularly, the presently disclosed subject matter relates to methods of providing sedation or analgesia to a pediatric patient by administering a dexmedetomidine infusion and optionally a loading dose. The dexmedetomidine can be administered before, during, or after surgery.Type: ApplicationFiled: November 16, 2015Publication date: March 10, 2016Applicant: HOSPIRA, INC.Inventors: Marcelo Garcia da Rocha, Wayne Wisemandle, Dennis Stalker, Edward Koo
-
Publication number: 20140005243Abstract: The presently disclosed subject matter relates to methods of administering an effective amount of dexmedetomidine to a pediatric patient in order to reduce the incidence of neurological damage. More particularly, the presently disclosed subject matter relates to methods of providing sedation or analgesia to a pediatric patient by administering a dexmedetomidine infusion and optionally a loading dose. The dexmedetomidine can be administered before, during, or after surgery.Type: ApplicationFiled: August 9, 2013Publication date: January 2, 2014Applicant: HOSPIRA, INC.Inventors: Marcelo Garcia da Rocha, Wayne Wisemandle, Dennis Stalker, Edward Koo
-
Patent number: 8507542Abstract: The presently disclosed subject matter relates to methods of administering an effective amount of dexmedetomidine to a pediatric patient in order to reduce the incidence of neurological damage. More particularly, the presently disclosed subject matter relates to methods of providing sedation or analgesia to a pediatric patient by administering a dexmedetomidine infusion and optionally a loading dose. The dexmedetomidine can be administered before, during, or after surgery.Type: GrantFiled: December 24, 2012Date of Patent: August 13, 2013Assignee: Hospira, Inc.Inventors: Marcelo Garcia da Rocha, Wayne Wisemandle, Dennis Stalker, Edward Koo
-
Publication number: 20130096170Abstract: The presently disclosed subject matter relates to methods of administering an effective amount of dexmedetomidine to a pediatric patient in order to reduce the incidence of neurological damage. More particularly, the presently disclosed subject matter relates to methods of providing sedation or analgesia to a pediatric patient by administering a dexmedetomidine infusion and optionally a loading dose. The dexmedetomidine can be administered before, during, or after surgery.Type: ApplicationFiled: January 4, 2012Publication date: April 18, 2013Applicant: HOSPIRA, INC.Inventors: Marcelo Garcia da Rocha, Wayne Wisemandle, Dennis James Stalker, Edward Koo
-
Patent number: 8324260Abstract: The presently disclosed subject matter relates to methods of administering an effective amount of dexmedetomidine to a pediatric patient in order to reduce the incidence of neurological damage. More particularly, the presently disclosed subject matter relates to methods of providing sedation or analgesia to a pediatric patient by administering a dexmedetomidine infusion and optionally a loading dose. The dexmedetomidine can be administered before, during, or after surgery.Type: GrantFiled: May 14, 2012Date of Patent: December 4, 2012Assignee: Hospira, Inc.Inventors: Marcelo Garcia da Rocha, Wayne Wisemandle, Dennis James Stalker, Edward Koo
-
Patent number: 7441253Abstract: A method and system for referring to and binding to objects using a moniker object is provided. In preferred embodiments a moniker object contains information to identify linked source data and provides methods through which a program can bind to the linked source data. A binding method is provided that returns an instance of an interface through which the linked source data can be accessed. In a preferred embodiment, the moniker object provides other methods including a reducing method that returns a more efficient representation of the moniker object; equality and hash methods for comparing moniker objects; and inverse, common prefix, and relative-path-to methods for comparing and locating moniker objects from other moniker objects. Several implementations of a moniker object are provided. Each implementation is a moniker class and has a class identifier that identifies code to manage the moniker class.Type: GrantFiled: July 3, 2006Date of Patent: October 21, 2008Assignee: Microsoft CorporationInventors: Robert G. Atkinson, Antony S. Williams, Edward Koo Jung
-
Publication number: 20080021085Abstract: The invention provides a method of preventing, delaying, or reversing the progression of Alzheimer's disease by administering an A?42 lowering agent to a mammal under conditions in which levels of A?42 are selectively reduced, levels of A?38 are increased, and levels of A?40 are unchanged. The invention provides methods and materials for developing and identifying A?42 lowering agents. In addition, the invention provides methods for identifying agents that increase the risk of developing, or hasten progression of, Alzheimer's disease. The invention also provides compositions of A?42 lowering agents and antioxidants, A?42 lowering agents and non-selective secretase inhibitors, as well as A?42 lowering agents and acetylcholinesterase inhibitors.Type: ApplicationFiled: June 21, 2007Publication date: January 24, 2008Applicants: Mayo Foundation for Medical Education and Research, The Regents of The University of CaliforniaInventors: Edward Koo, Todd Golde, Douglas Galasko, Sascha Weggen
-
Publication number: 20070253905Abstract: The invention provides a method of preventing, delaying, or reversing the progression of Alzheimer's disease by administering an A?42 lowering agent to a mammal under conditions in which levels of A?42 are selectively reduced, levels of A?38 are increased, and levels of A?40 are unchanged. The invention provides methods and materials for developing and identifying A?42 lowering agents. In addition, the invention provides methods for identifying agents that increase the risk of developing, or hasten progression of, Alzheimer's disease. The invention also provides compositions of A?42 lowering agents and antioxidants, A?42 lowering agents and non-selective secretase inhibitors, as well as A?42 lowering agents and acetylcholinesterase inhibitors.Type: ApplicationFiled: April 26, 2007Publication date: November 1, 2007Applicants: Mayo Foundation for Medical Education, The Regents of the University of CaliforniaInventors: Edward Koo, Todd Golde, Sascha Weggen
-
Publication number: 20070253906Abstract: The invention provides a method of preventing, delaying, or reversing the progression of Alzheimer's disease by administering an A?42 lowering agent to a mammal under conditions in which levels of A?42 are selectively reduced, levels of A?38 are increased, and levels of A?40 are unchanged. The invention provides methods and materials for developing and identifying A?42 lowering agents. In addition, the invention provides methods for identifying agents that increase the risk of developing, or hasten progression of, Alzheimer's disease. The invention also provides compositions of A?42 lowering agents and antioxidants, A?42 lowering agents and non-selective secretase inhibitors, as well as A?42 lowering agents and acetylcholinesterase inhibitors.Type: ApplicationFiled: April 26, 2007Publication date: November 1, 2007Applicants: Mayo Foundation for Medical Education and Research, The Regents of the University of CaliforniaInventors: Edward Koo, Todd Golde, Sascha Weggen
-
Publication number: 20050186559Abstract: The invention provides a method of preventing, delaying, or reversing the progression of Alzheimer's disease by administering an A?42 lowering agent to a mammal under conditions in which levels of A?42 are selectively reduced, levels of A?38 are increased, and levels of A?40 are unchanged. The invention provides methods and materials for developing and identifying A?42 lowering agents. In addition, the invention provides methods for identifying agents that increase the risk of developing, or hasten progression of, Alzheimer's disease. The invention also provides compositions of A?42 lowering agents and antioxidants, A?42 lowering agents and non-selective secretase inhibitors, as well as A?42 lowering agents and acetylcholinesterase inhibitors.Type: ApplicationFiled: April 25, 2005Publication date: August 25, 2005Applicants: Mayo Foundation for Medical Education and Research, The Regents of The University of CaliforniaInventors: Edward Koo, Todd Golde, Douglas Galasko, Sacha Weggen
-
Publication number: 20050089945Abstract: The invention provides a method of preventing, delaying, or reversing the progression of Alzheimer's disease by administering an A?42 lowering agent to a mammal under conditions in which levels of A?42 are selectively reduced, levels of A?38 are increased, and levels of A?40 are unchanged. The invention provides methods and materials for developing and identifying A?42 lowering agents. In addition, the invention provides methods for identifying agents that increase the risk of developing, or hasten progression of, Alzheimer's disease. The invention also provides compositions of A?42 lowering agents and antioxidants, A?42 lowering agents and non-selective secretase inhibitors, as well as A?42 lowering agents and acetylcholinesterase inhibitors.Type: ApplicationFiled: August 27, 2004Publication date: April 28, 2005Applicant: The Regents of the University of CaliforniaInventors: Edward Koo, Todd Golde
-
Patent number: 6230212Abstract: A method and system for tracking, and resolving links to, objects that derive from a common object creation is provided. In a system, the system creates a source object. The system then generates a lineage identifier to identify the creation of the source object. Then the system associates the lineage identifier with the source object. At a later time, the system copies the created object to a copy object. When the source object is copied to a copy object, the system associates the lineage identifier associated with the source object with the copy object. In this way, the lineage identifier associated with the copy object indicates that the copy object derives from the creation of the source object. The system links a client object to a source object by storing a link containing the source object's lineage identifier in the client object. A link also contains information for distinguishing the source object from other objects having the same lineage identifier.Type: GrantFiled: May 28, 1997Date of Patent: May 8, 2001Assignee: Microsoft CorporationInventors: William Paul Morel, Edward Koo Young Jung
-
Patent number: 5721919Abstract: A method and system for tracking, and resolving links to, objects that derive from a common object creation is provided. In a system, the system creates a source object. The system then generates a lineage identifier to identify the creation of the source object. Then the system associates the lineage identifier with the source object. At a later time, the system copies the created object to a copy object. When the source object is copied to a copy object, the system associates the lineage identifier associated with the source object with the copy object. In this way, the lineage identifier associated with the copy object indicates that the copy object derives from the creation of the source object.The system links a client object to a source object by storing a link containing the source object's lineage identifier in the client object. A link also contains information for distinguishing the source object from other objects having the same lineage identifier.Type: GrantFiled: June 20, 1994Date of Patent: February 24, 1998Assignee: Microsoft CorporationInventors: William Paul Morel, Edward Koo Young Jung